Cargando…
Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer
The development of an effective therapeutic intervention for liver cancer is a worldwide challenge that remains to be adequately addressed. Of note, TP53, which encodes the p53 protein, is an important tumor suppressor gene, 61% of TP53 is functionally inactivated in liver cancer. Recombinant human...
Autores principales: | Qu, Juan, Lu, Wei, Chen, Ming, Gao, Wei, Zhang, Cong, Guo, Bin, Yang, Jizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471865/ https://www.ncbi.nlm.nih.gov/pubmed/32934683 http://dx.doi.org/10.3892/etm.2020.9145 |
Ejemplares similares
-
Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers
por: Li, Yi, et al.
Publicado: (2021) -
Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis
por: Liu, Yehong, et al.
Publicado: (2016) -
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
por: Guo, Yaru, et al.
Publicado: (2021) -
Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer
por: QI, JIN-SONG, et al.
Publicado: (2015) -
Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial
por: Xiao, Jie, et al.
Publicado: (2017)